d-alpha tocopherol has been researched along with Leukemia, Megakaryocytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, NPH; Cheng, FWT; Chow, TTW; Chu, WCW; Feng, J; Lam, GKS; Leung, AWK; Li, CK; Ng, MHL | 1 |
| Anagnostou, A; Ciaramella, JM; Li, W; Sigounas, G; Steiner, M | 1 |
2 other study(ies) available for d-alpha tocopherol and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
t(1;22)(p13;q13) Acute Megakaryoblastic Leukemia Complicated by Hepatic Fibrosis: Antifibrosis Therapy?
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Child, Preschool; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 22; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Keratolytic Agents; Leukemia, Megakaryoblastic, Acute; Liver Cirrhosis; Prognosis; Translocation, Genetic; Tretinoin | 2021 |
dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells.
Topics: Arachidonic Acid; Cell Adhesion; Cell Membrane; Cell Size; Cytosol; Dose-Response Relationship, Drug; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Protein Kinase C; Pseudopodia; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vitamin E | 1997 |